Weller, Jonathan; Katzendobler, Sophie; Niedermeyer, Sebastian
ORCID: https://orcid.org/0000-0003-2647-7256; Harter, Patrick N.; Herms, Jochen; Trumm, Christoph G. ORCID: https://orcid.org/0000-0002-1249-3338; Niyazi, Maximilian; Thon, Niklas; Tonn, Joerg-Christian and Stöcklein, Veit M.
(2023):
Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status.
In: Journal of Neuro-Oncology, Vol. 163, No. 2: pp. 407-415
[PDF, 1MB]
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine > Institute for Diagnostic and Interventional Neuroradiology Medicine > Medical Center of the University of Munich > Neurosurgical Clinic and Polyclinic Medicine > Medical Center of the University of Munich > Clinic and Polyclinic for Radiotherapy and Radiooncology |
| Subjects: | 600 Technology > 610 Medicine and health |
| URN: | urn:nbn:de:bvb:19-epub-116459-2 |
| ISSN: | 0167-594X |
| Language: | English |
| Item ID: | 116459 |
| Date Deposited: | 15. May 2024, 06:18 |
| Last Modified: | 15. May 2024, 06:18 |
Actions (login required)
- View Item
